COPD assessment test (CAT): Simple tool for evaluating quality of life of chemical warfare patients with chronic obstructive pulmonary disease

Clinical Respiratory Journal

Volumn 8, Issue 1, 2014, Pages 116-123

  Lari, Shahrzad M ^a   Ghobadi, Hassan ^b   Attaran, Davood ^a   Mahmoodpour, Afsoun ^b   Shadkam, Omid ^a   Rostami, Maryam ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

COPD; Quality of life; Spirometry; Sulphur mustard

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; MUSCARINIC AGENT;

ADULT; ARTICLE; BODY MASS INDEX OBSTRUCTION DYSPNEA AND EXERCISE INDEX; CHEMICAL WARFARE; CHEST TIGHTNESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; COPD ASSESSMENT TEST; COUGHING; DEMOGRAPHY; DETERIORATION; DISEASE DURATION; DISEASE SEVERITY; DYSPNEA; FORCED EXPIRATORY VOLUME; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE STAGING; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXIMETRY; OXYGEN THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; VALIDITY;

COPD; QUALITY OF LIFE; SPIROMETRY; SULPHUR MUSTARD;

ADULT; CHEMICAL WARFARE AGENTS; CROSS-SECTIONAL STUDIES; HUMANS; IRAN; MALE; MIDDLE AGED; MUSTARD GAS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; WAR;

EID: 84891824478     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12047     Document Type: Article

References (35)

1. Balali-Mood M, Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol. 2006;99(4): 273-282.
2. Attaran D, Lari SM, Towhidi M, Marallu HG, Ayatollahi H, Khajehdaluee M, Ghanei M, Basiri R. Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2010;5: 335-340.
3. Ghanei M, Amiri S, Akbari H, Kosari F, Khalili AR, Alaeddini F, Aslani J, Giardina C, Haines DD. Correlation of sulfur mustard exposure and tobacco use with expression (immunoreactivity) of p53 protein in bronchial epithelium of Iranian 'mustard lung' patients. Mil Med. 2007;172(1): 70-74.
4. Attaran D, Lari SM, Khajehdaluee M, Ayatollahi H, Towhidi M, Marallu HG, Mazloomi M, Mood MB. Highly sensitive C-reactive protein levels in Iranian patients with pulmonary complication of sulfur mustard poisoning and its correlation with severity of airway diseases. Hum Exp Toxicol. 2009;28(12): 739-745.
5. Lari SM, Attaran D, Towhidi M. COPD due sulfur mustard (Mustard lung). In: Ong KC, editor. Chronic Obstructive Pulmonary Disease - Current Concepts and Practice. Croatia, InTech, 2012: 231-238.
6. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. Incidence of lung, eye, and skin lesions as late complications in 34, 000 Iranians with wartime exposure to mustard agent. J Occup Environ Med. 2003;45(11): 1136-1143.
7. Mahler DA. How should health-related quality of life be assessed in patients with COPD? Chest. 2000;117(Suppl. 2): 54S-58.
8. Attaran D, Khajedaloui M, Jafarzadeh R, Mazloomi M. Health related quality of life in patients with chemical warfare induced COPD. Arch Iran Med. 2006;9(4): 359-363.
9. Jones PW, Brusselle G, Dal Negro RW, etal. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1): 29-35.
10. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6): 932-946.
11. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Leidy K. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3): 648-654.
12. Jones PW, Tabberer M, Chen WH. Creating scenarios of the impact of COPD and their relationship to COPD assessment test (CAT™) scores. BMC Pulm Med. 2011;11: 42.
13. Gold PM. The 2007 GOLD Guidelines: a comprehensive care framework. Respiratory Care. 2009;54(8): 1040-1049.
14. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Developement, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes. 2003;1: 13.
15. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers W. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42(10): 773-778.
16. Jones PW, Quirk FH, Baveystock CM. The St Georges respiratory questionnaire. Respir Med. 1991;85(Suppl. B): 25-31.
17. Kelly JL, Bamsey O, Smith C, Lord VM, Shrikrishna D, Jones PW, Polkey MI, Hopkinson NS. Health status assessment in routine clinical practice: the chronic obstructive pulmonary disease assessment test score in outpatients. Respiration. 2012;84(3): 193-199.
18. Mackay AJ, Donaldson GC, Patel AR, Jones PW, Hurst JR, Wedzicha JA. Utility of the COPD Assessment Test (CAT) to Evaluate Severity of COPD Exacerbations. Am J Respir Crit Care Med. 2012;185(1): 1218-1224.
19. Jones PW, Harding G, Wiklund I, Berry P, Tabberer M, Yu R, Leidy NK. Tests of the responsiveness of the chronic obstructive pulmonary disease (COPD assessment test TM (CAT) following acute exacerbation and pulmonary rehabilitation). Chest. 2012;142(1): 134-140.
20. Dodd JW, Hogg L, Nolan J, Jefford H, Grant A, Lord VM, etal. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicenter, prospective study. Thorax. 2011;66(5): 425-429.
21. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;52: S77-S121.
22. Jones PW, Spencer S, Adie S. The St George Respiratory Questionnaire Manual. London, Respiratory Medicine, 2003.
23. Halvani A, Pourfarokh P, Nasiriani K. Quality of life and related factors in patients with chronic obstructive pulmonary disease. Tanaffos. 2006;5: 51-56.
24. Available at: http://www.catestonline.org/english/index_Farsi.htm CAT-Iran/Farsi, Version of Sep 10-Mapi Research Institute, GlaxoSmithKline).
25. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166: 111-117.
26. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10): 1005-1012.
27. Vestbo J, Hurd SS, Agustí AG, etal. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4): 347-365.
28. Weinberger B, Laskin JD, Sunil V, Sinko PJ, Heck DE, Laskin DL. Sulfur mustard - induced pulmonary injury: therapeutic approaches to mitigating toxicity. Pulm Pharmacol Ther. 2011;24(1): 92-99.
29. Poursaleh Z, Harandi AA, Vahedi E, Ghanei M. Treatment for sulfur mustard lung injuries; new therapeutic approaches from acute to chronic phase. Daru. 2012;20(1): 27.
30. Willemse BW, Postma DS, Timens W, ten Hacken NH. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J. 2004;23(3): 464-476.
31. Ebadi A, Ahmadi F, Ghanei M, Kazemnejad A. Concept and quality of life construct elements in chemical injured: a qualitative study. J Mil Med. 2010;12(1): 7-12.
32. Fadaii A, Sohrabpour H, Taherkhanchi B, Bagheri B. Association between COPD assessment test (CAT) and disease severity based on reduction of respiratory volumes in chemical warfare victims. Tanaffos. 2011;10(4): 38-42.
33. Medinas Amorós M, Mas-Tous C, Renom-Sotorra F, Rubí-Ponseti M, Centeno-Flores MJ, Gorriz-Dolz MT. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index. Chron Respir Dis. 2009;6(2): 75-80.
34. Ong KC, Lu SJ, Soh CS. Does the multidimensional grading system (BODE) correspond to differences inhealth status of patients with COPD? Int J Chron Obstruct Pulmon Dis. 2006;1(1): 91-96.
35. Marin JM, Cote CG, Diaz O, etal. Prognostic assessment in COPD: health related quality of life and the BODE index. Respir Med. 2011;105(6): 916-921.